{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T05:54:29Z","timestamp":1777874069096,"version":"3.51.4"},"reference-count":132,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007414","name":"Qassim University","doi-asserted-by":"publisher","award":["QU-APC-2025"],"award-info":[{"award-number":["QU-APC-2025"]}],"id":[{"id":"10.13039\/501100007414","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbial Pathogenesis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.micpath.2025.108224","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T17:10:21Z","timestamp":1764781821000},"page":"108224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Human metapneumovirus: Insights into immune evasion, pathogenesis and liposome-based vaccine strategies"],"prefix":"10.1016","volume":"211","author":[{"given":"Fahad A.","family":"Alhumaydhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hamza","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-4189","authenticated-orcid":false,"given":"Masood Alam","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micpath.2025.108224_bib1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1196\/annals.1408.005","article-title":"Avian and human metapneumovirus","volume":"1102","author":"Broor","year":"2007","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.micpath.2025.108224_bib2","doi-asserted-by":"crossref","unstructured":"van den Hoogen BG, de Jong JC, Groen J, Kuiken T, de Groot R, Fouchier RA, Osterhaus AD. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med.. 20017(6):719-724.","DOI":"10.1038\/89098"},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib3","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.canlet.2016.05.035","article-title":"Human metapneumovirus infections in hematopoietic cell transplant recipients and hematologic malignancy patients: a systematic review","volume":"379","author":"Shah","year":"2016","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.micpath.2025.108224_bib4","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1002\/cncr.30599","article-title":"Burden of human metapneumovirus infections in patients with cancer: risk factors and outcomes","volume":"123","author":"El","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.micpath.2025.108224_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101337","article-title":"Structural basis for respiratory syncytial virus and human metapneumovirus neutralization","volume":"61","author":"Miller","year":"2023","journal-title":"Curr. Opin. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1006\/viro.2001.1355","article-title":"Analysis of the genomic sequence of a human metapneumovirus","volume":"295","author":"van den Hoogen","year":"2002","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2025.108224_bib7","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.virusres.2015.02.024","article-title":"The Pneumovirinae fusion (F) protein: a common target for vaccines and antivirals","volume":"209","author":"Melero","year":"2015","journal-title":"Virus Res."},{"issue":"17","key":"10.1016\/j.micpath.2025.108224_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00723-22","article-title":"Evidence against the human metapneumovirus G, SH, and M2-2 proteins as bona fide interferon antagonists","volume":"96","author":"Groen","year":"2022","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00705-012-1492-7","article-title":"Seasonal distribution and epidemiological characteristics of human metapneumovirus infections in pediatric inpatients in Southeast China","volume":"158","author":"Wang","year":"2013","journal-title":"Arch. Virol."},{"key":"10.1016\/j.micpath.2025.108224_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ijid.2014.03.1394","article-title":"Human metapneumovirus: review of an important respiratory pathogen","volume":"25","author":"Panda","year":"2014","journal-title":"Int. J. Infect. Dis."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib11","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cll.2009.10.002","article-title":"Human metapneumovirus","volume":"30","author":"Hermos","year":"2010","journal-title":"Clin. Lab. Med."},{"issue":"4","key":"10.1016\/j.micpath.2025.108224_bib12","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/jpids\/piu100","article-title":"Respiratory tract infections due to human metapneumovirus in immunocompromised children","volume":"3","author":"Chu","year":"2014","journal-title":"J. Ped. Infect. Dis. Soc."},{"key":"10.1016\/j.micpath.2025.108224_bib13","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1435294","article-title":"Changes in the epidemiological patterns of respiratory syncytial virus and human metapneumovirus infection among pediatric patients and their correlation with severe cases: a long-term retrospective study","volume":"14","author":"Kuang","year":"2024","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.micpath.2025.108224_bib14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.ijid.2019.11.012","article-title":"Epidemiological and genetic characteristics of human metapneumovirus in pediatric patients across six consecutive seasons in Beijing, China","volume":"91","author":"Zhu","year":"2020","journal-title":"Int. J. Infect. Dis."},{"issue":"10 Suppl","key":"10.1016\/j.micpath.2025.108224_bib15","doi-asserted-by":"crossref","first-page":"S80","DOI":"10.1097\/INF.0b013e3181684dac","article-title":"Human metapneumovirus infection in adults","volume":"27","author":"Falsey","year":"2008","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"11","key":"10.1016\/j.micpath.2025.108224_bib16","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1128\/JVI.03261-13","article-title":"Human metapneumovirus SH and G glycoproteins inhibit macropinocytosis-mediated entry into human dendritic cells and reduce CD4+ T cell activation","volume":"88","author":"Le Nou\u00ebn","year":"2014","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.micpath.2025.108224_bib17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.idc.2021.07.007","article-title":"Health care-acquired viral respiratory diseases","volume":"35","author":"Petrie","year":"2021","journal-title":"Infect Dis Clin North Am."},{"key":"10.1016\/j.micpath.2025.108224_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107052","article-title":"Global analysis of respiratory viral circulation and timing of epidemics in the pre-COVID-19 and COVID-19 pandemic eras, based on data from the global influenza surveillance and response system (GISRS)","volume":"144","author":"Del Riccio","year":"2024","journal-title":"Int. J. Infect. Dis."},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib19","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/infdis\/jis333","article-title":"Comparison of risk factors for human metapneumovirus and respiratory syncytial virus disease severity in young children","volume":"206","author":"Papenburg","year":"2012","journal-title":"J. Infect. Dis."},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib20","doi-asserted-by":"crossref","first-page":"634","DOI":"10.3201\/eid0906.030017","article-title":"Human metapneumovirus infections in hospitalized children","volume":"9","author":"Boivin","year":"2003","journal-title":"Emerg. Infect. Dis."},{"issue":"7","key":"10.1016\/j.micpath.2025.108224_bib21","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1056\/NEJMoa1204630","article-title":"New vaccine surveillance network. Burden of human metapneumovirus infection in young children","volume":"368","author":"Edwards","year":"2013","journal-title":"N. Engl. J. Med."},{"issue":"4","key":"10.1016\/j.micpath.2025.108224_bib22","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1128\/CMR.00015-11","article-title":"Human metapneumovirus: lessons learned over the first decade","volume":"24","author":"Schildgen","year":"2011","journal-title":"Clin. Microbiol. Rev."},{"issue":"5","key":"10.1016\/j.micpath.2025.108224_bib23","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa025472","article-title":"Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children","volume":"350","author":"Williams","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12985-024-02327-9","article-title":"Epidemiology and diagnosis technologies of human metapneumovirus in China: a mini review","volume":"21","author":"Feng","year":"2024","journal-title":"Virol. J."},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib25","doi-asserted-by":"crossref","DOI":"10.4081\/idr.2010.e12","article-title":"Human metapneumovirus and respiratory syncytial virus: subtle differences but comparable severity","volume":"2","author":"Akhras","year":"2010","journal-title":"Infect. Dis. Rep."},{"key":"10.1016\/j.micpath.2025.108224_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1330209","article-title":"Human metapneumovirus respiratory infection affects both innate and adaptive intestinal immunity","volume":"15","author":"Sep\u00falveda-Alfaro","year":"2024","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108224_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104364","article-title":"An overview of progress in human metapneumovirus (hMPV) research: structure, function, and therapeutic opportunities","volume":"30","author":"Kr\u00fcger","year":"2025","journal-title":"Drug Discov. Today"},{"issue":"10","key":"10.1016\/j.micpath.2025.108224_bib28","doi-asserted-by":"crossref","first-page":"5971","DOI":"10.1128\/JVI.79.10.5971-5978.2005","article-title":"The immune response to human metapneumovirus is associated with aberrant immunity and impaired virus clearance in BALB\/c mice","volume":"79","author":"Alvarez","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.108224_bib29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1007\/s44162-025-00079-w","article-title":"Rising global threat of human metapneumovirus (hMPV in 2024\/2025): pathogenesis, immune dynamics, vulnerabilities in immunocompromised individuals, and lessons from past pandemics","volume":"4","author":"Andrar","year":"2025","journal-title":"J. Rare Dis."},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib30","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3390\/pathogens2020232","article-title":"Host-viral interactions: role of pattern recognition receptors (PRRs) in human pneumovirus infections","volume":"2","author":"Kolli","year":"2013","journal-title":"Pathogens"},{"key":"10.1016\/j.micpath.2025.108224_bib31","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.3389\/fimmu.2018.02466","article-title":"Human metapneumovirus: mechanisms and molecular targets used by the virus to avoid the immune system","volume":"9","author":"Soto","year":"2018","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2025.108224_bib32","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1128\/JVI.03275-14","article-title":"Role of type I interferon signaling in human metapneumovirus pathogenesis and control of viral replication","volume":"89","author":"Hastings","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.108224_bib33","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01213-12","article-title":"Critical role of MDA5 in the interferon response induced by human metapneumovirus infection in dendritic cells and In Vivo","volume":"87","author":"Ba\u00f1os-Lara","year":"2013","journal-title":"J. Virol."},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib34","doi-asserted-by":"crossref","first-page":"637","DOI":"10.3390\/v12060637","article-title":"Innate immune components that regulate the pathogenesis and resolution of hRSV and hMPV infections","volume":"12","author":"Andrade","year":"2020","journal-title":"Viruses"},{"issue":"10","key":"10.1016\/j.micpath.2025.108224_bib35","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3390\/vaccines12101198","article-title":"Interferon epsilon-mediated antiviral activity against human metapneumovirus and respiratory syncytial virus","volume":"12","author":"Mart\u00ednez-Espinoza","year":"2024","journal-title":"Vaccines"},{"key":"10.1016\/j.micpath.2025.108224_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00550-24","article-title":"IFN-\u03bb drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection","volume":"15","author":"Sojati","year":"2024","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/21505594.2016.1265725","article-title":"Aberrant T cell immunity triggered by human respiratory syncytial virus and human metapneumovirus infection","volume":"8","author":"Gonz\u00e1lez","year":"2017","journal-title":"Virulence"},{"key":"10.1016\/j.micpath.2025.108224_bib38","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1038\/s41385-021-00397-4","article-title":"Neutrophils in respiratory viral infections","volume":"14","author":"Johansson","year":"2021","journal-title":"Mucosal Immunol."},{"issue":"4","key":"10.1016\/j.micpath.2025.108224_bib39","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/iid3.500","article-title":"Role of neutrophils in acute viral infection","volume":"9","author":"Ma","year":"2021","journal-title":"Immun. Inflamm. Dis."},{"issue":"7","key":"10.1016\/j.micpath.2025.108224_bib40","article-title":"Human metapneumovirus pneumonia precipitating acute respiratory distress syndrome in an adult patient","volume":"13","author":"Tran","year":"2021","journal-title":"Cureus"},{"issue":"5","key":"10.1016\/j.micpath.2025.108224_bib41","doi-asserted-by":"crossref","first-page":"542","DOI":"10.3390\/v12050542","article-title":"Cell-mediated responses to human metapneumovirus infection","volume":"12","author":"Ballegeer","year":"2020","journal-title":"Viruses"},{"issue":"3","key":"10.1016\/j.micpath.2025.108224_bib42","article-title":"Global impact of hMPV virus: transmission, pathogenesis, diagnostic and treatment","volume":"112","author":"Sejal","year":"2025","journal-title":"Diagn. Microbiol. Infect. Dis."},{"issue":"17","key":"10.1016\/j.micpath.2025.108224_bib43","doi-asserted-by":"crossref","first-page":"8560","DOI":"10.1128\/JVI.00699-08","article-title":"T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection","volume":"82","author":"Kolli","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.108224_bib44","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12985-025-02782-y","article-title":"Human metapneumovirus (hMPV) in 2025: emerging trends and insights from community and hospital-based respiratory panel analyses-a comprehensive review","volume":"22","author":"Mohammadi","year":"2025","journal-title":"Virol. J."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.02122-23","article-title":"A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein","volume":"15","author":"Ballegeer","year":"2024","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib46","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1080\/1744666X.2025.2494658","article-title":"Host immune response to respiratory syncytial virus infection and its contribution to protection and susceptibility in adults: a systematic literature review","volume":"21","author":"Chaumont","year":"2025","journal-title":"Expet Rev. Clin. Immunol."},{"issue":"Pt 12","key":"10.1016\/j.micpath.2025.108224_bib47","doi-asserted-by":"crossref","first-page":"3113","DOI":"10.1099\/vir.0.2008\/005199-0","article-title":"Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus","volume":"89","author":"Ulbrandt","year":"2008","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.micpath.2025.108224_bib48","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/s41392-023-01471-y","article-title":"T cells in health and disease","volume":"8","author":"Sun","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"17","key":"10.1016\/j.micpath.2025.108224_bib49","doi-asserted-by":"crossref","first-page":"8713","DOI":"10.1128\/JVI.00670-15","article-title":"Lung CD8+ T cell impairment occurs during human metapneumovirus infection despite virus-like particle induction of functional CD8+ T cells","volume":"89","author":"Wen","year":"2015","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.micpath.2025.108224_bib50","doi-asserted-by":"crossref","first-page":"5108","DOI":"10.4049\/jimmunol.1302208","article-title":"Programmed death-1 impairs secondary effector lung CD8+ T cells during respiratory virus reinfection","volume":"193","author":"Erickson","year":"2014","journal-title":"J. Immunol."},{"issue":"25","key":"10.1016\/j.micpath.2025.108224_bib51","first-page":"240","article-title":"Resurgence of human metapneumovirus in the post-COVID-19 era: pathogenesis, epidemiological shifts, clinical impact, and future challenges","volume":"S1473\u20133099","author":"Liu","year":"2025","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.micpath.2025.108224_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1557880","article-title":"Receptors and host factors: key players in human metapneumovirus infection","volume":"15","author":"Dong","year":"2025","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"4","key":"10.1016\/j.micpath.2025.108224_bib53","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1128\/CMR.00081-15","article-title":"Modulation of host immunity by the human metapneumovirus","volume":"29","author":"C\u00e9spedes","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib54","doi-asserted-by":"crossref","DOI":"10.15190\/d.2025.3","article-title":"Clinical insights and advancements in human metapneumovirus management and prognosis","volume":"13","author":"Wilkhoo","year":"2025","journal-title":"Discoveries"},{"key":"10.1016\/j.micpath.2025.108224_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.970750","article-title":"Human metapneumovirus M2-2 protein inhibits RIG-I signaling by preventing TRIM25-mediated RIG-I ubiquitination","volume":"13","author":"Tanaka","year":"2022","journal-title":"Front. Immunol."},{"issue":"9","key":"10.1016\/j.micpath.2025.108224_bib56","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0024496","article-title":"Human metapneumovirus inhibits IFN-\u03b2 signaling by downregulating Jak1 and Tyk2 cellular levels","volume":"6","author":"Ren","year":"2011","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib57","doi-asserted-by":"crossref","first-page":"116","DOI":"10.7774\/cevr.2025.14.e12","article-title":"Minireview: designing next generation human metapneumovirus (HMPV) vaccine","volume":"14","author":"Saeed","year":"2025","journal-title":"Clin. Exp. Vaccine Res."},{"key":"10.1016\/j.micpath.2025.108224_bib58","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s13205-025-04384-5","article-title":"The dual threat: exploring the emergence of human metapneumovirus and SARS-CoV-2 coinfections in respiratory infections","volume":"15","author":"Goel","year":"2025","journal-title":"3 Biotech"},{"issue":"5","key":"10.1016\/j.micpath.2025.108224_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000077","article-title":"Human metapneumovirus glycoprotein G inhibits innate immune responses","volume":"4","author":"Bao","year":"2008","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib81","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/s41467-022-28931-3","article-title":"Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins","volume":"13","author":"Hsieh","year":"2022","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.micpath.2025.108224_bib82","doi-asserted-by":"crossref","first-page":"11259","DOI":"10.1073\/pnas.96.20.11259","article-title":"The M2-2 protein of human respiratory syncytial virus is a regulatory factor involved in the balance between RNA replication and transcription","volume":"96","author":"Bermingham","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.micpath.2025.108224_bib83","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01104-24","article-title":"Human metapneumovirus SH protein promotes JAK1 degradation to impair host IL-6 signaling","volume":"98","author":"Brynes","year":"2024","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.micpath.2025.108224_bib59","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.4049\/jimmunol.0902750","article-title":"Cell type-specific recognition of human metapneumoviruses (HMPVs) by retinoic acid-inducible gene I (RIG-I) and TLR7 and viral interference of RIG-I ligand recognition by HMPV-B1 phosphoprotein","volume":"184","author":"Goutagny","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.micpath.2025.108224_bib60","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1173605","article-title":"Human metapneumovirus driven IFN-\u03b2 production antagonizes macrophage transcriptional induction of IL1-\u03b2 in response to bacterial pathogens","volume":"14","author":"Loevenich","year":"2023","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib61","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/s41392-024-01980-4","article-title":"The multiple roles of interferon regulatory factor family in health and disease","volume":"9","author":"Wang","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib62","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.ajpath.2014.02.026","article-title":"IRF-3, IRF-7, and IPS-1 promote host defense against acute human metapneumovirus infection in neonatal mice","volume":"184","author":"Spann","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"3","key":"10.1016\/j.micpath.2025.108224_bib63","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/imm.12083","article-title":"Human metapneumovirus keeps dendritic cells from priming antigen-specific naive T cells","volume":"139","author":"C\u00e9spedes","year":"2013","journal-title":"Immunology"},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib64","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1016\/j.tig.2020.08.017","article-title":"Genetic lesions of type I interferon signalling in human antiviral immunity","volume":"37","author":"Duncan","year":"2021","journal-title":"Trends Genet."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.virol.2008.11.043","article-title":"Infection and maturation of monocyte-derived human dendritic cells by human respiratory syncytial virus, human metapneumovirus, and human parainfluenza virus type 3","volume":"385","author":"Le Nou\u00ebn","year":"2009","journal-title":"Virology"},{"key":"10.1016\/j.micpath.2025.108224_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.sbi.2024.102913","article-title":"RNA recognition in toll-like receptor signaling","volume":"88","author":"Shimizu","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.micpath.2025.108224_bib67","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.3389\/fimmu.2020.01513","article-title":"The role of dendritic cells during infections caused by highly prevalent viruses","volume":"11","author":"Soto","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2025.108224_bib68","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/v13030519","article-title":"Host components that modulate the disease caused by hMPV","volume":"13","author":"G\u00e1lvez","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib69","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12985-022-01949-1","article-title":"Profiles and predictive value of cytokines in children with human metapneumovirus pneumonia","volume":"19","author":"Xiang","year":"2022","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib70","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3390\/microorganisms8060824","article-title":"Human metapneumovirus establishes persistent infection in lung microvascular endothelial cells and primes a Th2-Skewed immune response","volume":"8","author":"Bugatti","year":"2020","journal-title":"Microorganisms"},{"key":"10.1016\/j.micpath.2025.108224_bib71","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.coi.2014.12.009","article-title":"Suppression of antigen presentation by IL-10","volume":"34","author":"Mittal","year":"2015","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.micpath.2025.108224_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1568828","article-title":"Interplay between endogenous hormones and immune systems in human metapneumovirus pathogenesis and management","volume":"16","author":"Ruiz-Pozo","year":"2025","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.micpath.2025.108224_bib73","doi-asserted-by":"crossref","unstructured":"Guerrero-Plata A, Casola A, Garofalo RP. Human metapneumovirus induces a profile Soto2005;79(23):14992-14997.","DOI":"10.1128\/JVI.79.23.14992-14997.2005"},{"key":"10.1016\/j.micpath.2025.108224_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1161067","article-title":"The multifaceted nature of IL-10: regulation, role in immunological homeostasis and its relevance to cancer, COVID-19 and post-COVID conditions","volume":"14","author":"Carlini","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.micpath.2025.108224_bib75","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/6104054","article-title":"IL-10: a multifunctional cytokine in viral infections","volume":"2017","author":"Rojas","year":"2017","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.micpath.2025.108224_bib76","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3389\/fimmu.2020.00487","article-title":"The role of PD-1 in acute and chronic infection","volume":"11","author":"Jubel","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.micpath.2025.108224_bib77","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.mucimm.2023.12.004","article-title":"PD-1 signaling in neonates restrains CD8+ T cell function and protects against respiratory viral immunopathology","volume":"17","author":"Eddens","year":"2024","journal-title":"Mucosal Immunol."},{"issue":"9","key":"10.1016\/j.micpath.2025.108224_bib78","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.immuni.2022.07.003","article-title":"Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein","volume":"55","author":"Rappazzo","year":"2022","journal-title":"Immunity"},{"issue":"9","key":"10.1016\/j.micpath.2025.108224_bib79","doi-asserted-by":"crossref","first-page":"e732","DOI":"10.1016\/S2666-5247(23)00134-9","article-title":"Neutralising antibodies against human metapneumovirus","volume":"4","author":"Guo","year":"2023","journal-title":"Lancet Microbe"},{"issue":"3","key":"10.1016\/j.micpath.2025.108224_bib84","article-title":"Divergent origins, divergent pandemic potential: a comparative analysis of HMPV and SARS-CoV-2","volume":"5","author":"Mozaffari","year":"2025","journal-title":"J. Clin. Virol."},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib85","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/21505594.2016.1265725","article-title":"Aberrant T cell immunity triggered by human respiratory syncytial virus and human metapneumovirus infection","volume":"8","author":"Gonz\u00e1lez","year":"2017","journal-title":"Virulence"},{"issue":"12","key":"10.1016\/j.micpath.2025.108224_bib86","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.1080\/21645515.2020.1833579","article-title":"Exploring the possible use of saponin adjuvants in COVID-19 vaccine","volume":"16","author":"Sharma","year":"2020","journal-title":"Hum. Vaccines Immunother."},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib87","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70056","article-title":"Novel vaccine strategies to induce respiratory mucosal immunity: advances and implications","volume":"6","author":"Zhou","year":"2025","journal-title":"MedComm"},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib88","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41541-025-01086-0","article-title":"Calboxyvinyl polymer adjuvant enhances respiratory iga responses through mucosal and systemic administration","volume":"10","author":"Sasaki","year":"2025","journal-title":"npj Vaccines"},{"issue":"9","key":"10.1016\/j.micpath.2025.108224_bib89","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.immuni.2022.07.003","article-title":"Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein","volume":"55","author":"Rappazzo","year":"2022","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib90","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"Wykes","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2025.108224_bib91","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1054005","article-title":"Virus-like particles containing a prefusion-stabilized F protein induce a balanced immune response and confer protection against respiratory syncytial virus infection in mice","volume":"13","author":"Luo","year":"2022","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.micpath.2025.108224_bib92","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1016\/S1473-3099(16)00119-5","article-title":"Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?","volume":"16","author":"Saso","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"Pt 7","key":"10.1016\/j.micpath.2025.108224_bib93","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1099\/vir.0.000083","article-title":"Recent vaccine development for human metapneumovirus","volume":"96","author":"Ren","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib94","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jcv.2007.10.022","article-title":"Vaccination approaches to combat human metapneumovirus lower respiratory tract infections","volume":"41","author":"Herfst","year":"2008","journal-title":"J. Clin. Virol."},{"issue":"24","key":"10.1016\/j.micpath.2025.108224_bib95","doi-asserted-by":"crossref","first-page":"15114","DOI":"10.1128\/JVI.79.24.15114-15122.2005","article-title":"Chimeric recombinant human metapneumoviruses with the nucleoprotein or phosphoprotein open reading frame replaced by that of avian metapneumovirus exhibit improved growth in vitro and attenuation in vivo","volume":"79","author":"Pham","year":"2005","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib96","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1093\/jpids\/pix006","article-title":"Evaluation of a live attenuated human metapneumovirus vaccine in adults and children","volume":"7","author":"Karron","year":"2018","journal-title":"J. Pediatric. Infect. Dis. Soc."},{"issue":"19","key":"10.1016\/j.micpath.2025.108224_bib97","doi-asserted-by":"crossref","first-page":"11411","DOI":"10.1128\/JVI.00876-14","article-title":"Rational design of human metapneumovirus live attenuated vaccine candidates by inhibiting viral mRNA cap methyltransferase","volume":"88","author":"Zhang","year":"2014","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.micpath.2025.108224_bib98","doi-asserted-by":"crossref","first-page":"6588","DOI":"10.1128\/JVI.79.11.6588-6597.2005","article-title":"Deletion of M2 gene open reading frames 1 and 2 of human metapneumovirus: effects on RNA synthesis, attenuation, and immunogenicity","volume":"79","author":"Buchholz","year":"2005","journal-title":"J. Virol."},{"issue":"Pt 4","key":"10.1016\/j.micpath.2025.108224_bib99","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1099\/vir.0.000031","article-title":"Adjuvant effect of the human metapneumovirus (HMPV) matrix protein in HMPV subunit vaccines","volume":"96","author":"Aerts","year":"2015","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib100","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3390\/pathogens9020135","article-title":"Engineering of live chimeric vaccines against human metapneumovirus","volume":"9","author":"Ogonczyk Makowska","year":"2020","journal-title":"Pathogens"},{"issue":"9","key":"10.1016\/j.micpath.2025.108224_bib101","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.vaccine.2020.01.047","article-title":"Evaluation of pre- and post-fusion human metapneumovirus F proteins as subunit vaccine candidates in mice","volume":"38","author":"Pilaev","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.108224_bib102","article-title":"Lipid nanoparticles in the development of mRNA vaccines for COVID-19","volume":"74","author":"Wilson","year":"2022","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"7","key":"10.1016\/j.micpath.2025.108224_bib103","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac206","article-title":"Safety and immunogenicity of an mRNA-Based human metapneumovirus and parainfluenza virus type 3 combined vaccine in healthy adults","volume":"9","author":"August","year":"2022","journal-title":"Open Forum Infect. Dis."},{"issue":"3","key":"10.1016\/j.micpath.2025.108224_bib104","article-title":"Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus","volume":"19","author":"Ma","year":"2023","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.micpath.2025.108224_bib105","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10409230802058320","article-title":"Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme","volume":"43","author":"White","year":"2008","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib106","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00705-013-1622-x","article-title":"Human metapneumovirus G protein is highly conserved within but not between genetic lineages","volume":"158","author":"Yang","year":"2013","journal-title":"Arch. Virol."},{"issue":"7","key":"10.1016\/j.micpath.2025.108224_bib107","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3390\/v13071214","article-title":"Functional features of the respiratory syncytial virus G protein","volume":"13","author":"Anderson","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micpath.2025.108224_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.962925","article-title":"Role of human metapneumovirus glycoprotein G in modulation of immune responses","volume":"13","author":"Velayutham","year":"2022","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.micpath.2025.108224_bib109","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3390\/v10060278","article-title":"Human metapneumovirus small hydrophobic protein inhibits interferon induction in plasmacytoid dendritic cells","volume":"10","author":"Bao","year":"2018","journal-title":"Viruses"},{"issue":"9","key":"10.1016\/j.micpath.2025.108224_bib110","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.00809-24","article-title":"Small hydrophobic (SH) proteins of pneumoviridae and paramyxoviridae: small but mighty","volume":"98","author":"Brynes","year":"2024","journal-title":"J. Virol."},{"key":"10.1016\/j.micpath.2025.108224_bib111","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01243-24","article-title":"The role of M2 proteins of pneumoviruses in transcription regulation, prevention of hypermutation, and activation of the type I interferon pathway","author":"Rib\u00f3-Molina","year":"2025","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.micpath.2025.108224_bib112","doi-asserted-by":"crossref","first-page":"949","DOI":"10.3390\/vaccines9090949","article-title":"Role of NKT cells during viral infection and the development of NKT cell-based nanovaccines","volume":"9","author":"Khan","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib113","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3390\/molecules27020403","article-title":"Liposome-mediated delivery of MERS antigen induces potent humoral and cell-mediated immune response in mice","volume":"27","author":"Khan","year":"2022","journal-title":"Molecules"},{"issue":"8","key":"10.1016\/j.micpath.2025.108224_bib114","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1021\/acs.molpharmaceut.1c00447","article-title":"Lipid-based nanoparticles for delivery of vaccine adjuvants and antigens: toward multicomponent vaccines","volume":"18","author":"Chatzikleanthous","year":"2021","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.micpath.2025.108224_bib116","article-title":"The role of lipid components in lipid nanoparticles for vaccines and gene therapy","volume":"188","author":"Hald","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.micpath.2025.108224_bib117","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jconrel.2012.07.012","article-title":"Manipulation of the surface pegylation in combination with reduced vesicle size of cationic liposomal adjuvants modifies their clearance kinetics from the injection site, and the rate and type of T cell response","volume":"164","author":"Kaur","year":"2012","journal-title":"J. Contr. Release"},{"issue":"22","key":"10.1016\/j.micpath.2025.108224_bib118","doi-asserted-by":"crossref","first-page":"7790","DOI":"10.3390\/molecules27227790","article-title":"Glycosphingolipids (GSLs) from Sphingomonas paucimobilis increase the efficacy of liposome-based nanovaccine against acinetobacter baumannii-Associated pneumonia in immunocompetent and immunocompromised mice","volume":"27","author":"Khan","year":"2022","journal-title":"Molecules"},{"issue":"5","key":"10.1016\/j.micpath.2025.108224_bib119","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2022.e09394","article-title":"Liposomes: structure, composition, types, and clinical applications","volume":"8","author":"Nsairat","year":"2022","journal-title":"Heliyon"},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib120","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/s41541-023-00781-0","article-title":"Co-adjuvanting DDA\/TDB liposomes with a TLR7 agonist allows for IgG2a\/c class-switching in the absence of Th1 cells","volume":"8","author":"Zimmermann","year":"2023","journal-title":"npj Vaccines"},{"issue":"4","key":"10.1016\/j.micpath.2025.108224_bib121","doi-asserted-by":"crossref","first-page":"571","DOI":"10.3390\/immuno2040036","article-title":"Harnessing nasal immunity with IgA to prevent respiratory infections","volume":"2","author":"Joseph","year":"2022","journal-title":"Immuno"},{"issue":"8","key":"10.1016\/j.micpath.2025.108224_bib122","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/mt.2008.122","article-title":"Efficient MHC class I presentation by controlled intracellular trafficking of antigens in octaarginine-modified liposomes","volume":"16","author":"Nakamura","year":"2008","journal-title":"Mol. Ther."},{"issue":"2","key":"10.1016\/j.micpath.2025.108224_bib123","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/nri3152","article-title":"Expanding roles for CD4+ T cells in immunity to viruses","volume":"12","author":"Swain","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.micpath.2025.108224_bib124","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3389\/fimmu.2014.00171","article-title":"T cell responses to viral infections - opportunities for peptide vaccination","volume":"5","author":"Rosendahl Huber","year":"2014","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.micpath.2025.108224_bib125","doi-asserted-by":"crossref","first-page":"4577","DOI":"10.1016\/j.apsb.2024.06.006","article-title":"Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes","volume":"14","author":"Wan","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"issue":"5","key":"10.1016\/j.micpath.2025.108224_bib126","doi-asserted-by":"crossref","first-page":"667","DOI":"10.3390\/pharmaceutics16050667","article-title":"Swelling, rupture and endosomal escape of biological nanoparticles per Se and those fused with liposomes in acidic environment","volume":"16","author":"Ponomareva","year":"2024","journal-title":"Pharmaceutics"},{"issue":"Pt A","key":"10.1016\/j.micpath.2025.108224_bib127","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.micpath.2025.108224_bib128","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.micpath.2025.108224_bib129","first-page":"770","article-title":"Targeted drug delivery using tuftsin-bearing liposomes: implications in the treatment of infectious diseases and tumors","volume":"22","author":"Khan","year":"2021","journal-title":"Curr. Drug Targets"},{"issue":"31","key":"10.1016\/j.micpath.2025.108224_bib130","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.1016\/j.vaccine.2017.05.070","article-title":"Liposomes containing monophosphoryl lipid A and QS-21 serve as an effective adjuvant for soluble circumsporozoite protein malaria vaccine FMP013","volume":"35","author":"Genito","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.micpath.2025.108224_bib131","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/978-1-4939-6445-1_5","article-title":"QS-21 adjuvant: laboratory-scale purification method and formulation into liposomes","volume":"1494","author":"Brunner","year":"2017","journal-title":"Methods Mol. Biol."},{"issue":"5","key":"10.1016\/j.micpath.2025.108224_bib132","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1021\/mp2003835","article-title":"Encapsulating immunostimulatory CpG oligonucleotides in listeriolysin O-liposomes promotes a Th1-type response and CTL activity","volume":"9","author":"Andrews","year":"2012","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.micpath.2025.108224_bib133","first-page":"1","article-title":"Liposomes as adjuvants and vaccine delivery systems","volume":"16","author":"Tretiakova","year":"2022","journal-title":"Biochem. (Mosc) Suppl. Ser. A Membr. Cell Biol."}],"container-title":["Microbial Pathogenesis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025009490?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0882401025009490?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T18:54:41Z","timestamp":1777575281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0882401025009490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":132,"alternative-id":["S0882401025009490"],"URL":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108224","relation":{},"ISSN":["0882-4010"],"issn-type":[{"value":"0882-4010","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human metapneumovirus: Insights into immune evasion, pathogenesis and liposome-based vaccine strategies","name":"articletitle","label":"Article Title"},{"value":"Microbial Pathogenesis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micpath.2025.108224","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"108224"}}